Tag: inter partes review
AG Mukasey Winning WSJ Debate Over Fintiv Denials
The recent back-and-forth in the Wall Street Journal between former Attorney General Michael Mukasey and former Federal Circuit Chief Judge Paul Michel is telling about the state of the debate over PT...
Fintiv: More Work, Less Quality
When the Patent Trial and Appeal Board (PTAB or “Board”) first decided the IPR that led to the Fintiv rule, it justified its decision on the basis of “balanc[ing] considerations such as system e...
A Solution to the OpenSky Problem
I have written several times about the $2.2 billion verdict in the VLSI v. Intel case. The case is extraordinary not just because of the size of the verdict, but because Intel was blocked from c...
Fintiv Analysis Proves That Fintiv Is Being Used To Leave Likely Invalid Patents In Force
A recently released study from Unified Patents has put numbers to the sense many patent attorneys already had—the Patent Trial and Appeal Board is spending a lot of time on Fintiv discretionary deni...
The Pat-Signal Is Going Dark—Senator Leahy Won’t Seek Re-Election
Senator Patrick Leahy (D-VT) has announced that he won’t be seeking re-election to the Senate for a ninth term. First elected in 1974, Senator Leahy has spent nearly 50 years in the Senate, focuse...
Arthrex, Mobility Workx, and Director Review at Institution
There’s been a fair amount of discussion regarding Judge Newman’s dissent in last week’s Mobility Workx case. In Mobility Workx, a divided panel of the Federal Circuit rejected a variety o...
Leahy and Cornyn Introduce Bill To Restore The America Invents Act
Yesterday, Senate Judiciary IP Subcommittee Chair Sen. Leahy (D-VT) and committee member Sen. Cornyn (R-TX) introduced the Restoring the America Invents Act (RAIA). RAIA would roll back changes ...
Patent Quality Week: Public Interest Patents, The AIA At Ten, And More
This week marks the first annual Patent Quality Week. Low quality patents can have huge negative impacts on business sectors from Main Street retailers to Silicon Valley startups, and everywhere...
Arthrex Is Here—What Will It Mean?
Yesterday, the Supreme Court handed down its much-awaited decision—at least, much-awaited by people who care about patents and the Patent Trial and Appeal Board (PTAB)—in the consolidated U.S. v A...